Since the establishment of the international business department, the company has gradually entered the international market and achieved good sales results. The company's international business has always adhered to the "best reputation, best service, best quality" philosophy. After five years of development, it has established a good reputation among customers around the world and has been rated as "Best" by many users. "Suppliers", product sales increased year by year, and the company was named as one of the top five Chinese exporters of Chinese medicine in 2010 by the Medical Insurance Chamber of Commerce.
The company's products have been sold to the United States, Japan, India, Pakistan, South Korea, Brazil, Egypt, Jordan, Iran, Indonesia, Syria, Canada, Mexico, Taiwan, Hong Kong and other dozens of countries and regions.
In the process of internationalization of the company, we attach great importance to the internationalization of the quality system, and demand ourselves with the standards of ICH and cGMP. At present, the company's cGMP system has gradually integrated with Europe and the United States, and has passed through Colombia, Japan, Indonesia, Pakistan, Nigeria, Official on-site inspections in countries such as South Korea have passed audits of suppliers from dozens of world-renowned customers.
In terms of international registration, the company has obtained 15 USDMF, 1 JDMF, 3 KDMF, 6 CEP certificates and 17 Indian registration certificates.
The company's main export products are: potassium clavulanate series products, isoflurane, sevoflurane, enzymatic phenolic acid, 4-AA, miglitol, isosorbide mononitrate and so on.